Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Autoimmune Disorders

  Free Subscription

Articles published in J Rheumatol

Retrieve available abstracts of 105 articles:
HTML format

Single Articles

    November 2022
  1. FIGUEROA-PARRA G, Jeffery MM, Dabit JY, Chevet B, et al
    Long-term opioid therapy among patients with systemic lupus erythematosus in the community. A Lupus Midwest Network study.
    J Rheumatol. 2022 Nov 15. pii: jrheum.220822. doi: 10.3899/jrheum.220822.
    PubMed     Abstract available

  2. OGURO N, Yajima N, Miyawaki Y, Yoshimi R, et al
    Impact of communicative and critical health literacy on trust in physicians among patients with systemic lupus erythematosus: the TRUMP(2)-SLE project.
    J Rheumatol. 2022 Nov 15. pii: jrheum.220678. doi: 10.3899/jrheum.220678.
    PubMed     Abstract available

  3. YOSHINARI M, Hattanda F, Nishibata Y, Masuda S, et al
    A Novel Antineutrophil Extracellular Trap Antibody Targeting Myosin Light Chain 6 in Microscopic Polyangiitis.
    J Rheumatol. 2022;49:1286-1288.

  4. JOHNSON SR, Martinez JPD, Whittall-Garcia L, Urowitz MB, et al
    Evaluating the threshold score for classification of systemic lupus erythematosus using the EULAR/ACR criteria.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220100. doi: 10.3899/jrheum.220100.
    PubMed     Abstract available

  5. ZHUO N, Wang G, Li J, Liu Y, et al
    Systemic Lupus Erythematosus Flares During Dialysis in Patients With Endstage Renal Disease.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220947. doi: 10.3899/jrheum.220947.
    PubMed     Abstract available

  6. SEO P, Winthrop K, Sawalha AH, Choi S, et al
    Physicians' perspective on vaccination in patients with autoimmune inflammatory rheumatic diseases: an international survey.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220135. doi: 10.3899/jrheum.220135.
    PubMed     Abstract available

    October 2022
  7. DUARTE GARCIA A, Yazdany J
    Cardiovascular Disease Disparities in Systemic Lupus Erythematosus.
    J Rheumatol. 2022 Oct 15. pii: jrheum.220933. doi: 10.3899/jrheum.220933.
    PubMed     Abstract available

  8. ALHAMMADI NA, Gladman DD, Su J, Urowitz MB, et al
    Isolated Neutropenia in Systemic Lupus Erythematosus.
    J Rheumatol. 2022 Oct 15. pii: jrheum.220373. doi: 10.3899/jrheum.220373.
    PubMed     Abstract available

    The Big Bad Wolf: Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus.
    J Rheumatol. 2022;49:1082-1084.

  10. LAHIRY P, Naumenko S, Couse M, Liao F, et al
    Hemophagocytic Lymphohistiocytosis Gene Variants in Childhood-Onset Systemic Lupus Erythematosus With Macrophage Activation Syndrome.
    J Rheumatol. 2022;49:1146-1151.
    PubMed     Abstract available

  11. TOLLISEN A, Selvaag AM, Aasland A, Ingebrigtsen T, et al
    Personally Generated Quality of Life Outcomes in Adults With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2022;49:1138-1145.
    PubMed     Abstract available

    September 2022
  12. DAVIS A, Faerber J, Ardalan K, Katcoff H, et al
    The Impact of Psychiatric Comorbidity on Health Care Utilization for Youth with Newly Diagnosed Systemic Lupus Erythematosus.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220052. doi: 10.3899/jrheum.220052.
    PubMed     Abstract available

  13. STULL C, Sprow G, Werth VP
    Cutaneous Involvement in Systemic Lupus Erythematous: A Review for the Rheumatologist.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220089. doi: 10.3899/jrheum.220089.
    PubMed     Abstract available

  14. XU A, Chen J, Wang X, Ye S, et al
    Pneumomediastinum and Subcutaneous Facial Emphysema in Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220521. doi: 10.3899/jrheum.220521.
    PubMed     Abstract available

  15. MARTINEZ PEREZ JM, Mollerach FB, Scaglioni V, Vergara F, et al
    Incidence and Prevalence of Polymyalgia Rheumatica and Giant Cell Arteritis in a Healthcare Management Organization in Buenos Aires, Argentina.
    J Rheumatol. 2022 Sep 1. pii: jrheum.220084. doi: 10.3899/jrheum.220084.
    PubMed     Abstract available

  16. SUN K, Coles TM, Voils CI, Anderson DR, et al
    Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of Extent of and Reasons for Medication Nonadherence.
    J Rheumatol. 2022 Sep 1. pii: jrheum.220399. doi: 10.3899/jrheum.220399.
    PubMed     Abstract available

  17. SEVIM E, Siddique S, Chalasani MLS, Chyou S, et al
    Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo.
    J Rheumatol. 2022;49:1026-1030.
    PubMed     Abstract available

  18. SHOOP-WORRALL SJW, Moull L, McDonagh JE, Hyrich KL, et al
    The Role of Age in Delays to Rheumatological Care in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2022;49:1037-1041.
    PubMed     Abstract available

    August 2022
  19. CHUNG SH, Oshima K, Singleton M, Thomason J, et al
    Determinants of Cervical Cancer Screening Patterns Among Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220105. doi: 10.3899/jrheum.220105.
    PubMed     Abstract available

  20. KIM YE, Choi SJ, Lim DH, Kim H, et al
    Disease Flare of Systemic Lupus Erythematosus in Patients With Endstage Renal Disease on Dialysis.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220101. doi: 10.3899/jrheum.220101.
    PubMed     Abstract available

  21. SCHLETZBAUM M, Kind AJ, Chen Y, Astor BC, et al
    Age-Stratified Thirty-Day Rehospitalization and Mortality and Predictors of Rehospitalization among Patients with Systemic Lupus Erythematosus: a Medicare cohort study.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220025. doi: 10.3899/jrheum.220025.
    PubMed     Abstract available

  22. MATSUDA S, Kotani T, Kuwabara H, Suzuka T, et al
    Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung Disease.
    J Rheumatol. 2022;49:913-921.
    PubMed     Abstract available

  23. TREFOND L, Sauret A, Stievenart J, Olagne L, et al
    Dr. Trefond et al reply: Giant Cell Arteritis After SARS-CoV-2 Vaccination-Coincidence or Trigger ?
    J Rheumatol. 2022;49:964.

  24. KALLAS R, Li J, Goldman DW, Magder LS, et al
    Trajectory of Damage Accrual in Systemic Lupus Erythematosus based on Ethnicity and Socioeconomic Factors.
    J Rheumatol. 2022 Aug 1. pii: jrheum.211135. doi: 10.3899/jrheum.211135.
    PubMed     Abstract available

  25. GARG S, Bartels CM, Bao G, Helmick CG, et al
    Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities.
    J Rheumatol. 2022 Aug 1. pii: jrheum.220279. doi: 10.3899/jrheum.220279.
    PubMed     Abstract available

  26. NOZAWA T, Bell-Peter A, Marcuz JA, Whitney K, et al
    Early abnormal nailfold capillary changes are predictive of calcinosis development in juvenile dermatomyositis.
    J Rheumatol. 2022 Aug 1. pii: jrheum.220249. doi: 10.3899/jrheum.220249.
    PubMed     Abstract available

    July 2022

  27. Canadian Rheumatology Association Annual Meeting, February 2-5, 2022.
    J Rheumatol. 2022;49:751-847.
    PubMed     Abstract available

  28. LOIZIDIS G, Rabinowitz MR, Tuluc M
    IgG4-related Disease With Destructive Nasal Bone Involvement Leading to Saddle Nose Deformity.
    J Rheumatol. 2022;49:748-749.

    Uveitis in Juvenile Psoriatic Arthritis: Still So Much To Learn.
    J Rheumatol. 2022;49:661-662.

  30. BAQUET-WALSCHEID K, Rothaus K, Niewerth M, Klotsche J, et al
    Occurrence and Risk Factors of Uveitis in Juvenile Psoriatic Arthritis: Data From a Population-based Nationwide Study in Germany.
    J Rheumatol. 2022;49:719-724.
    PubMed     Abstract available

  31. TREFOND L, Sauret A, Stievenart J, Olagne L, et al
    Dr. Trefond et al reply: Giant Cell Arteritis After SARS-CoV-2 Vaccination-Coincidence or Trigger?
    J Rheumatol. 2022;49:860.

  32. CHEVET B, Figueroa-Parra G, Yang JX, Hulshizer CA, et al
    COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN).
    J Rheumatol. 2022 Jul 1. pii: jrheum.220220. doi: 10.3899/jrheum.220220.
    PubMed     Abstract available

    June 2022
  33. LV C, You H, Xu L, Wang L, et al
    Coexisting of anti-Ro52 autoantibodies on anti-MDA5 autoantibodies-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220139. doi: 10.3899/jrheum.220139.
    PubMed     Abstract available

  34. SIMONS G, Falahee M
    Fear of the Unknown: Can We Help Individuals With a Systemic Autoimmune Rheumatic Disease Deal With Uncertainty?
    J Rheumatol. 2022 Jun 1. pii: jrheum.220502. doi: 10.3899/jrheum.220502.
    PubMed     Abstract available

  35. MARINO A, Orsini F, Pregnolato F, Cimaz R, et al
    Tumor Necrosis Factor-alpha Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study.
    J Rheumatol. 2022;49:654-656.

  36. BOLHUIS TE, Nizet LEA, Owen C, den Broeder AA, et al
    Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review.
    J Rheumatol. 2022;49:627-634.
    PubMed     Abstract available

  37. MAHESWARANATHAN M, Eudy AM, Barr AC, Howe C, et al
    Association of Health Literacy and Numeracy With Lupus Knowledge and the Creation of the Lupus Knowledge Assessment Test.
    J Rheumatol. 2022;49:585-591.
    PubMed     Abstract available

    May 2022
  38. MINIAOUI I, Morel N, Levesque K, Maltret A, et al
    Health Outcome of 215 Mothers of Children with Autoimmune Congenital Heart Block: Analysis of the French Neonatal Lupus Syndrome Registry.
    J Rheumatol. 2022 May 2. pii: jrheum.210703. doi: 10.3899/jrheum.210703.
    PubMed     Abstract available

  39. MCHUGH A, Chan A, Herrera C, Park JM, et al
    Profiling Behavioral and Psychological Symptoms in Children Undergoing Treatment for Spondyloarthritis and Polyarthritis.
    J Rheumatol. 2022;49:489-496.
    PubMed     Abstract available

  40. EL TAL T, Ryan ME, Feldman BM, Bingham CA, et al
    Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.
    J Rheumatol. 2022;49:497-503.
    PubMed     Abstract available

    April 2022
  41. LALLY L, Narula N, Goodfellow N, Luqmani R, et al
    Rho Kinase Expression in Giant Cell Arteritis: Validating pERM Intensity Score to Increase Sensitivity of Temporal Artery Biopsy.
    J Rheumatol. 2022 Apr 15. pii: jrheum.220012. doi: 10.3899/jrheum.220012.
    PubMed     Abstract available

  42. KUWANA M, Wakasugi N, Furuya T, Uno S, et al
    Tacrolimus in patients with interstitial pneumonia associated with polymyositis or dermatomyositis: interim report of post-marketing surveillance in Japan.
    J Rheumatol. 2022 Apr 15. pii: jrheum.210322. doi: 10.3899/jrheum.210322.
    PubMed     Abstract available

  43. WALLACE ZS, Cook C, Finkelstein-Fox L, Fu X, et al
    The Association of Illness-Related Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2022 Apr 1. pii: jrheum.211084. doi: 10.3899/jrheum.211084.
    PubMed     Abstract available

  44. NOONE DG, Silverman ED
    Treatment of Childhood-onset Proliferative Lupus Nephritis in the 21st Century: A Call to Catch Up With the Evidence.
    J Rheumatol. 2022 Apr 1. pii: jrheum.220196. doi: 10.3899/jrheum.220196.
    PubMed     Abstract available

  45. GIANCANE G, Papa R, Vastert S, Bagnasco F, et al
    Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry.
    J Rheumatol. 2022;49:398-407.
    PubMed     Abstract available

    March 2022
  46. MCDERMOTT G, Gill R, Gagne S, Byrne S, et al
    Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211242. doi: 10.3899/jrheum.211242.
    PubMed     Abstract available

  47. HADWEN B, Yu R, Cairns E, Barra L, et al
    Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211020. doi: 10.3899/jrheum.211020.
    PubMed     Abstract available

  48. LIU Y, Xiao F, Zhang R, Zhang X, et al
    Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus?
    J Rheumatol. 2022 Mar 15. pii: jrheum.220023. doi: 10.3899/jrheum.220023.
    PubMed     Abstract available

  49. SUN G, Yafasova A, Baslund B, Faurschou M, et al
    Long-term Risk of Heart Failure and Other Adverse Cardiovascular Outcomes in Granulomatosis With Polyangiitis: A Nationwide Cohort Study.
    J Rheumatol. 2022;49:291-298.
    PubMed     Abstract available

    February 2022
  50. JAMES W, Ogunrinde E, Wan Z, Kamen DL, et al
    A distinct plasma microbiome but not gut microbiome in patients with systemic lupus erythematosus compared to healthy individuals.
    J Rheumatol. 2022 Feb 15. pii: jrheum.210952. doi: 10.3899/jrheum.210952.
    PubMed     Abstract available

  51. CANNON L, Wenderfer SE, Lewandowski LB, Cooper JC, et al
    Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-onset Systemic Lupus Erythematosus in North America.
    J Rheumatol. 2022 Feb 15. pii: jrheum.210428. doi: 10.3899/jrheum.210428.
    PubMed     Abstract available

  52. CHANG Y, Di W, Wu J
    Systemic Lupus Erythematosus Increases the Risk of Gestational Diabetes: Truth or Illusion?
    J Rheumatol. 2022 Feb 1. pii: jrheum.211374. doi: 10.3899/jrheum.211374.
    PubMed     Abstract available

  53. PEREZ ACOSTA ME, Meyers AB, Toth MB
    Cystic Ganglionosis in a 3-year-old Mimicking Juvenile Idiopathic Arthritis.
    J Rheumatol. 2022;49:230-231.

    January 2022
  54. FAIR DC, Nocton JJ, Panepinto JA, Yan K, et al
    Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis Correlate With Pain and Stress Using PROMIS Measures.
    J Rheumatol. 2022;49:74-80.
    PubMed     Abstract available

    December 2021
  55. LI Z, Li D, Lv P, Liu J, et al
    Brain Abscess Due to Nocardia in a Patient With Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Dec 1. pii: jrheum.210971. doi: 10.3899/jrheum.210971.
    PubMed     Abstract available

  56. VAN VOLLENHOVEN RF, Hahn BH, Tsokos GC, Lipsky P, et al
    Efficacy and Safety of Ustekinumab in Patients with Active Systemic Lupus Erythematosus: Results Through 2 Years of an Open-Label Extension in a Phase 2 Study.
    J Rheumatol. 2021 Dec 1. pii: jrheum.210805. doi: 10.3899/jrheum.210805.
    PubMed     Abstract available

  57. GERNAAT SAM, Simard JF, Wikstrom AK, Svenungsson E, et al
    Gestational Diabetes Mellitus Risk in Pregnant Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Dec 1. pii: jrheum.210087. doi: 10.3899/jrheum.210087.
    PubMed     Abstract available

  58. TOUSSIROT E, Michaud M, Wendling D, Devauchelle V, et al
    Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica.
    J Rheumatol. 2021;48:1888-1889.

  59. DAVE I, Estroff B, Gergely T, Rostad CA, et al
    Impact of the Season of Birth on the Development of Juvenile Idiopathic Arthritis in the United States: A Nationwide Registry-based Study.
    J Rheumatol. 2021;48:1856-1862.
    PubMed     Abstract available

  60. AESCHLIMANN FA, Raimondi F, Leiner T, Aquaro GD, et al
    Overview of imaging in adult- and childhood-onset Takayasu arteritis.
    J Rheumatol. 2021 Dec 1. pii: jrheum.210368. doi: 10.3899/jrheum.210368.
    PubMed     Abstract available

    November 2021
  61. IWAMOTO T, Dorschner JM, Selvaraj S, Mezzano V, et al
    High Systemic Type I Interferon Activity is Associated with Active Class III/IV Lupus Nephritis.
    J Rheumatol. 2021 Nov 15. pii: jrheum.210391. doi: 10.3899/jrheum.210391.
    PubMed     Abstract available

  62. CURTIS JR, Zhou X, Rubin DT, Reinisch W, et al
    Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients with Autoimmune Conditions Treated with Systemic Therapies: a Population-based Study.
    J Rheumatol. 2021 Nov 15. pii: jrheum.210888. doi: 10.3899/jrheum.210888.
    PubMed     Abstract available

  63. WOJCIK S, Inman RD, Nakamura A
    IgG4-related Disease in a Patient With Ankylosing Spondylitis: Clues to Common Immunopathogenesis.
    J Rheumatol. 2021;48:1757-1758.

  64. MENDEL A, Pagnoux C
    Use of Rituximab for the Treatment of Antineutrophil Cytoplasm Antibody-associated Vasculitis in Canada, 2010-2020.
    J Rheumatol. 2021;48:1755-1756.

  65. SPRINGER JM, Funk RS
    Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    J Rheumatol. 2021;48:1718-1724.
    PubMed     Abstract available

  66. BERARD R, Batthish M
    Addressing Healthcare Quality in Juvenile Idiopathic Arthritis With a Universal Access Program.
    J Rheumatol. 2021;48:1635-1638.

  67. CONCHA S, Morales PS, Talesnik E, Borzutzky A, et al
    Changes in Treatments and Outcomes After Implementation of a National Universal Access Program for Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:1725-1731.
    PubMed     Abstract available

    October 2021
  68. CARBONE T, Picerno V, Pafundi V, Esposito E, et al
    Impact of COVID-19 pandemic on appropriateness of diagnostic pathways of autoimmune diseases.
    J Rheumatol. 2021 Oct 15. pii: jrheum.210611. doi: 10.3899/jrheum.210611.
    PubMed     Abstract available

  69. GOULENOK T, Francois C, Mendes C, Farhi F, et al
    Improving COVID-19 vaccine coverage in patients with autoimmune and inflammatory diseases.
    J Rheumatol. 2021 Oct 15. pii: jrheum.210534. doi: 10.3899/jrheum.210534.
    PubMed     Abstract available

  70. SAURET A, Stievenart J, Smets P, Olagne L, et al
    Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype?
    J Rheumatol. 2021 Oct 1. pii: jrheum.210724. doi: 10.3899/jrheum.210724.
    PubMed     Abstract available

  71. ULLOA AC, Liao F, Carlomagno RL, Dia T, et al
    Schizophrenia Genetics and Neuropsychiatric Features in Childhood-Onset Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Oct 1. pii: jrheum.210363. doi: 10.3899/jrheum.210363.
    PubMed     Abstract available

  72. ROSS C, Elfassy HL, Makhzoum JP
    Somatic Mutation in UBA1 and ANCA-associated Vasculitis.
    J Rheumatol. 2021;48:1626-1627.

    September 2021
  73. LIEBER SB, Nahid M, Paget S, Berman JR, et al
    Evaluation of a Patient-Reported Frailty Tool in Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Sep 1. pii: jrheum.201466. doi: 10.3899/jrheum.201466.
    PubMed     Abstract available

    August 2021
  74. WANG X, Hefton A, Ni K, Ukadike KC, et al
    Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in rheumatoid arthritis patients.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201492. doi: 10.3899/jrheum.201492.
    PubMed     Abstract available

  75. FALASINNU T, Drenkard C, Bao G, Mackey S, et al
    The Problem of Pain in Systemic Lupus Erythematosus: An Explication of the Role of Biopsychosocial Mechanisms.
    J Rheumatol. 2021;48:1279-1289.
    PubMed     Abstract available

    July 2021
  76. RUPERTO N, Brunner HI, Tzaribachev N, Vega-Cornejo G, et al
    Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:1073-1081.
    PubMed     Abstract available

  77. ZHAO Y, Iyer RS, Thapa M, Biswas D, et al
    A Novel Algorithm using Within-leg Calibration for Enhanced Accuracy of Detection of Arthritis by Infrared Thermal Imaging in Children.
    J Rheumatol. 2021 Jul 1. pii: jrheum.210077. doi: 10.3899/jrheum.210077.
    PubMed     Abstract available

  78. WALLACE ZS, Yun H, Curtis JR, Chen L, et al
    ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry.
    J Rheumatol. 2021;48:1060-1064.
    PubMed     Abstract available

  79. CRAIG J, Feldman BM, Spiegel L, Dover S, et al
    Comparing the Measurement Properties and Preferability of Patient-reported Outcome Measures in Pediatric Rheumatology: PROMIS vs CHAQ.
    J Rheumatol. 2021;48:1065-1072.
    PubMed     Abstract available

  80. SUN K, Eudy AM, Criscione-Schreiber LG, Sadun RE, et al
    Racial Differences in Patient-provider Communication, Patient Self-efficacy, and Their Associations With Systemic Lupus Erythematosus-related Damage: A Cross-sectional Survey.
    J Rheumatol. 2021;48:1022-1028.
    PubMed     Abstract available

    June 2021
    Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Jun 15. pii: jrheum.210024. doi: 10.3899/jrheum.210024.
    PubMed     Abstract available

  82. AL AWQATI MZ, Sluzevich JC, Berianu F
    Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-gamma Antibody.
    J Rheumatol. 2021 Jun 15. pii: jrheum.200399. doi: 10.3899/jrheum.200399.
    PubMed     Abstract available

    Giant Cell Arteritis: Real-life Experience.
    J Rheumatol. 2021 Jun 1. pii: jrheum.210334. doi: 10.3899/jrheum.210334.
    PubMed     Abstract available

  84. GROOT N, Kardolus A, Bijl M, Dolhain RJEM, et al
    Effects of Childhood-onset Systemic Lupus Erythematosus on Academic Achievements and Employment in Adult Life.
    J Rheumatol. 2021;48:915-923.
    PubMed     Abstract available

    May 2021
  85. HAZLEWOOD GS, Pardo J, Barnabe C, Schieir O, et al
    Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases.
    J Rheumatol. 2021 May 15. pii: jrheum.210288. doi: 10.3899/jrheum.210288.
    PubMed     Abstract available

  86. RAHMAN A
    Why Do Patients With Systemic Lupus Erythematosus Suffer Pain?
    J Rheumatol. 2021 May 1. pii: jrheum.210057. doi: 10.3899/jrheum.210057.
    PubMed     Abstract available

  87. REZAEI E, Newkirk MM, Li Z, Gordon JR, et al
    Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:760-766.
    PubMed     Abstract available

    April 2021
  88. DIAZ T, Dominguez D, Jaeggi E, Knight A, et al
    Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort.
    J Rheumatol. 2021 Apr 1. pii: jrheum.201338. doi: 10.3899/jrheum.201338.
    PubMed     Abstract available

  89. LANGLEBEN D, Berkson L, Chartrand S
    Selexipag Therapy for Raynaud Phenomenon-induced Severe Digital Ischemia in Intravenous Epoprostenol Responders With Connective Tissue Disease.
    J Rheumatol. 2021;48:616-617.

  90. JAYNE D
    Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?
    J Rheumatol. 2021;48:479-481.

  91. SCHNEIDER J, Venhoff N, Walz G
    Ruptured Intrarenal Arterial Aneurysm in a Patient With Granulomatosis With Polyangiitis.
    J Rheumatol. 2021;48:615.

  92. GKROUZMAN E, Sevim E, Finik J, Andrade D, et al
    Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository.
    J Rheumatol. 2021;48:541-547.
    PubMed     Abstract available

  93. MENDEL A, Ennis D, Go E, Bakowsky V, et al
    CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update.
    J Rheumatol. 2021;48:555-566.
    PubMed     Abstract available

  94. LUO Y, Xu J, Jiang C, Krittanawong C, et al
    Trends in the Inpatient Burden of Coronary Artery Disease in Granulomatosis With Polyangiitis: A Study of a Large National Dataset.
    J Rheumatol. 2021;48:548-554.
    PubMed     Abstract available

  95. MALLER J, Fox E, Park KT, Paul SS, et al
    Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:567-574.
    PubMed     Abstract available

    March 2021
  96. BERTI A, Specks U
    The Survival of Patients With Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    J Rheumatol. 2021;48:314-317.

    What It Means to Me to Have Juvenile Arthritis: One Patient's Definition.
    J Rheumatol. 2021;48:470.

  98. TANG S, Li X, Zhao KY, Zhou Q, et al
    Clinical Characteristics and Prognostic Analysis of Microscopic Polyangiitis With Diffuse Alveolar Hemorrhage.
    J Rheumatol. 2021;48:410-416.
    PubMed     Abstract available

  99. ONO N, Inoue Y, Miyamura T, Ueda N, et al
    The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
    J Rheumatol. 2021;48:417-425.
    PubMed     Abstract available

    February 2021
  100. KORKUS D, Gazitt T, Cohen AD, Feldhamer I, et al
    Increased Prevalence of Systemic Lupus Erythematosus Comorbidity in Patients With Psoriatic Arthritis: A Population-based Case-control Study.
    J Rheumatol. 2021;48:207-213.
    PubMed     Abstract available

  101. PETRI M, Barr E, Magder LS
    Risk of Renal Failure Within 10 or 20 Years of Systemic Lupus Erythematosus Diagnosis.
    J Rheumatol. 2021;48:222-227.
    PubMed     Abstract available

  102. WALSCHEID K, Glandorf K, Rothaus K, Niewerth M, et al
    Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in Germany.
    J Rheumatol. 2021;48:262-269.
    PubMed     Abstract available

    January 2021
  103. AGARWAL S
    Update on Sweet Syndrome in Eosinophilic Granulomatosis With Polyangiitis.
    J Rheumatol. 2021;48:151.

    September 2019
  104. BOLLHALDER A, Patcas R, Eichenberger M, Muller L, et al
    Magnetic Resonance Imaging Follow-up of Temporomandibular Joint Inflammation, Deformation and Mandibular Growth in Juvenile Idiopathic Arthritis Patients on Systemic Treatment.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190168. doi: 10.3899/jrheum.190168.
    PubMed     Abstract available

    March 2019
  105. BANERJEE S, Quinn KA, Gribbons KB, Rosenblum JS, et al
    Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-Vessel Vasculitis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181222. doi: 10.3899/jrheum.181222.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.